| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/29/2013 | US20130225536 Methods for Accelerated Return of Skin Integrity and for the Treatment of Impetigo |
| 08/29/2013 | US20130225533 Docosahexaenoic acid bound in phospholipids and method of recovering same from a natural source |
| 08/29/2013 | US20130225531 Method and composition for treating alzheimer's disease and dementias of vascular origin |
| 08/29/2013 | US20130225530 Wogonin for the prevention and therapy of cardiac hypertrophy |
| 08/29/2013 | US20130225529 Phospho-ester derivatives and uses thereof |
| 08/29/2013 | US20130225526 Medicine, food and drink or feed containing sphingomyelin |
| 08/29/2013 | US20130225525 Combined Treatment Utilizing VB-201 |
| 08/29/2013 | US20130225524 Chemical Compounds |
| 08/29/2013 | US20130225518 Methods for treating cancer using tor kinase inhibitor combination therapy |
| 08/29/2013 | US20130225517 Therapeutic Compounds |
| 08/29/2013 | US20130225516 Topical compositions comprising fipronil and permethrin and methods of use |
| 08/29/2013 | US20130225515 Method for isolating small molecules with important biological activity using yeast |
| 08/29/2013 | US20130225513 Methods and formulations for treating sialic acid deficiencies |
| 08/29/2013 | US20130225502 Combination therapy with w t 1 peptide vaccine and temozolomide |
| 08/29/2013 | US20130225499 Method for administering omega-conopeptide |
| 08/29/2013 | US20130225487 Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives |
| 08/29/2013 | US20130225486 Cysteine and food intake |
| 08/29/2013 | US20130225480 Method of Treating Chronic Obstructive Pulmonary Disease |
| 08/29/2013 | US20130225412 Silicon nanocarrier for delivery of drug, pesticides and herbicides , and for waste water treatment |
| 08/29/2013 | US20130224320 Process to improve feed efficiency and carcass characteristics of animals |
| 08/29/2013 | US20130224317 Methods and materials for reducing multiple risk factors associated with the metabolic syndrome |
| 08/29/2013 | US20130224313 Cancer therapy method |
| 08/29/2013 | US20130224311 Methods and compositions for the treatment of cancer |
| 08/29/2013 | US20130224310 Noscapine analogs and their use in treating cancers |
| 08/29/2013 | US20130224306 Method for treating a pulmonary hypertension condition without companion diagnosis |
| 08/29/2013 | US20130224301 Solid pharmaceutical dispersions with enhanced bioavailability |
| 08/29/2013 | US20130224299 Novel Process For The Preparation Of Roflumilast |
| 08/29/2013 | US20130224298 Two-Phase Preparation And Use Thereof For The Treatment Of Herpes |
| 08/29/2013 | US20130224297 Pharmaceutical composition comprising krebs cycle precursor salt, in particular citrate salt, and use thereof as a medicament |
| 08/29/2013 | US20130224296 Drug Formulations Using Water Soluble Antioxidants |
| 08/29/2013 | US20130224295 Granule and orally-disintegrating tablet containing drug causing bitterness |
| 08/29/2013 | US20130224293 Pharmaceutical composition and administrations thereof |
| 08/29/2013 | US20130224292 Acamprosate formulations, methods of using the same, and combinations comprising the same |
| 08/29/2013 | US20130224291 Delayed-release formulation for reducing the frequency of urination and method of use thereof |
| 08/29/2013 | US20130224290 Oral Pharmaceutical Composition of Duloxetine |
| 08/29/2013 | US20130224289 Gastric retained gabapentin dosage form |
| 08/29/2013 | US20130224286 Methods and compositions for treating pox virus infections |
| 08/29/2013 | US20130224283 Biphasic lipid-vesicle composition and method for treating cervical dysplasia by intravaginal delivery |
| 08/29/2013 | US20130224281 Method and composition for ameliorating the effects for a subject exposed to radiation or other sources of oxidative stress |
| 08/29/2013 | US20130224280 Transdermal compositions and methods for treating stretch marks |
| 08/29/2013 | US20130224272 Compositions and methods for treating demodex infestations |
| 08/29/2013 | US20130224262 Transdermal preparation |
| 08/29/2013 | US20130224259 Dimethylarginine Dimethylaminohydrolase Inhibitors and Methods of Use Thereof |
| 08/29/2013 | US20130224257 Method for preparing microspheres and microspheres produced thereby |
| 08/29/2013 | US20130224256 Hydrogel nanocomposite wound dressing and a method of synthesizing the same |
| 08/29/2013 | US20130224255 Treatment Of Diabetic Patients With A Drug Eluting Stent And Adjunctive Therapy |
| 08/29/2013 | US20130224250 Purified Plasmodium and Vaccine Composition |
| 08/29/2013 | US20130224240 Method of reducing weight using composition containing fucoxanthin extract |
| 08/29/2013 | US20130224239 Alcoholic extract of fungi of genus cunninghamella and use thereof |
| 08/29/2013 | US20130224227 Novel conjugates of cc-1065 analogs and bifunctional linkers |
| 08/29/2013 | US20130224218 Methods and Compositions for the Inhibition of Fructokinase |
| 08/29/2013 | US20130224214 Compositions and Methods for Therapy and Diagnosis of Cancer and Cancer Metastasis |
| 08/29/2013 | US20130224195 Substituted benzazoles and methods of their use as inhibitors of raf kinase |
| 08/29/2013 | US20130224192 Method for the prognosis of the progression of cancer |
| 08/29/2013 | US20130224189 Tweak receptor |
| 08/29/2013 | US20130224186 Oxazole and thiazole compounds as ksp inhibitors |
| 08/29/2013 | US20130224177 Method of regulating fertilizing ability using cyclic adp-ribose and cd38 |
| 08/29/2013 | US20130224172 Methods of treating behavioral symptoms of neurological and mental disorders |
| 08/29/2013 | US20130224170 Method of ameliorating oxidative stress and supplementing the diet |
| 08/29/2013 | US20130224169 Composition and method for recovery from mild traumatic brain injury |
| 08/29/2013 | US20130224164 Environmental Clostridial Bacteriotherapy and Related Formulations and Methods of Manufacture and Use |
| 08/29/2013 | US20130224163 Neuronal specific targeting of caveolin expression to restore synaptic signaling and improve cognitive function in the neurodegenerative brain and motor function in spinal cord |
| 08/29/2013 | US20130224152 Spiro[2.4]heptanes for Treatment of Flaviviridae Infections |
| 08/29/2013 | US20130224151 Use of FAAH Inhibitors for Treating Abdominal, Visceral and Pelvic Pain |
| 08/29/2013 | US20130224149 Process for preparing antiviral compounds |
| 08/29/2013 | US20130224147 Macrocyclic serine protease inhibitors |
| 08/29/2013 | US20130224135 Diarylalkanes as potent inhibitors of binuclear enzymes |
| 08/29/2013 | US20130224123 Nanoparticulate compositions having lysozyme as a surface stabilizer |
| 08/29/2013 | US20130224118 Perhexiline for treating chronic heart failure |
| 08/29/2013 | US20130224110 Use of adenosine receptor signaling to modulate permeability of blood-brain barrier |
| 08/29/2013 | US20130224107 Heterocyclic derivates, preparation processes and medical uses thereof |
| 08/29/2013 | US20130220871 Method of providing pirfenidone therapy to a patient |
| 08/29/2013 | DE102013202928A1 Verfahren und Zusammensetzungen zum Behandeln von Krebsmetastasierung Methods and compositions for treating cancer metastasis |
| 08/29/2013 | DE102012101680A1 Pharmazeutische Zubereitung enthaltend ein antiviral wirksames Dihydrochinazolinderivat Pharmaceutical composition comprising an antivirally effective Dihydrochinazolinderivat |
| 08/29/2013 | DE102012101671A1 Composition useful for treating and preventing hypercholesterolaemia, rheumatoid arthritis and/or neurodegenerative disorders, comprises first compound e.g. celecoxib and etoricoxib, and second compound e.g. indoprofen and mefenamic acid |
| 08/29/2013 | DE102012101659A1 Salze eines Dihydrochinazolinderivats Salts of Dihydrochinazolinderivats |
| 08/29/2013 | DE102012101557A1 Verwendung von microRNAs oder Genen als Marker zur Identifizierung, Diagnose und Therapie einzelner nicht-ischämischer Kardiomyopathien oder Speichererkrankungen des Herzens Use of miRNAs or genes as markers for the identification, diagnosis and treatment of individual non-ischemic cardiomyopathies or storage diseases of the heart |
| 08/29/2013 | DE102012004132A1 Kohlenstoffmonoxid freisetzende Materialien und deren Verwendung Carbon monoxide-releasing materials and their use |
| 08/29/2013 | DE102012003725A1 Galenic composition, used for topical application on skin and/or mucous membrane, comprises ceramide or ceramide mixture having specified concentration, mixture of surfactant and cosurfactant, lipophilic phase, and hydrophilic phase |
| 08/29/2013 | CA2857262A1 Antiviral compounds |
| 08/29/2013 | CA2848798A1 Formulation of doxylamine and pyridoxine and/or metabolites or salts thereof |
| 08/28/2013 | EP2631648A2 Therapeutic target for periodontal disease. |
| 08/28/2013 | EP2631291A2 Nucleic acid molecules inducing rna interference, and uses thereof |
| 08/28/2013 | EP2631239A1 2',4'-substituted nucleosides as antiviral agents |
| 08/28/2013 | EP2631238A1 Spirocyclic inhibitors of serine proteases for the treatment of hcv infections |
| 08/28/2013 | EP2631236A1 Substituted pyrazolo[1,5-a]pyridines, their preparation and use as medicaments |
| 08/28/2013 | EP2631233A1 Antagonist for mutated androgen receptor |
| 08/28/2013 | EP2631232A1 Halogen derivatives of benzo[b]furans useful as anti-neoplastic or anti-proliferative drugs |
| 08/28/2013 | EP2631229A1 P2x4 receptor antagonist |
| 08/28/2013 | EP2630971A1 Combinations of albumin-based drug delivery systems |
| 08/28/2013 | EP2630960A1 Transdermal Delivery of Beneficial Substances Effected by a Hostile Biophysical Environment |
| 08/28/2013 | EP2630958A1 Solutions for bicarbonate hemodialysis |
| 08/28/2013 | EP2630957A1 Method of treating animal drinking water with interval dosing of a biocide |
| 08/28/2013 | EP2630956A2 Sustained-release pellets containing tacrolimus as an active ingredient |
| 08/28/2013 | EP2630955A1 Immediate release and sustained release ibuprofen dosing regimen |
| 08/28/2013 | EP2630954A1 Pulmonary delivery for levodopa |
| 08/28/2013 | EP2630951A1 Oral suspension of prednisolone acetate |
| 08/28/2013 | EP2630493A2 Antigen-specific, tolerance-inducing microparticles and uses thereof |
| 08/28/2013 | EP2630241A2 Treatment of alpha-l-iduronidase (idua) related diseases by inhibition of natural antisense transcript to idua |
| 08/28/2013 | EP2630150A2 6-amido derivatives of 4,5a-epoxymorphinans for treatment of pain |